Month: November 2021

Under cross-examination, the founder of the failed blood testing start-up defended herself but admitted that she had made mistakes. View original article Contributor: Erin Griffith

The company said that analyses and modeling of mutations in the variant suggest that they may weaken the effect of the treatment, but that studies using Omicron’s full sequences have not been completed. View original article Contributor: Benjamin Mueller

Cervical cancer is a preventable and treatable disease. Yet, it kills about 300,000 women annually worldwide. The World Health Organization is hoping to get that number to zero by 2030. … Click to Continue » View original article Contributor:

If an expert committee votes to recommend it, the drug, molnupiravir, could be authorized within days for patients at high risk of severe illness. View original article Contributor: Rebecca Robbins and Carl Zimmer

Rising Covid cases have spurred a return to mask-wearing in the U.S. and overseas, at a time when flawed KN95s from China continue to dominate e-commerce sites. View original article Contributor: Andrew Jacobs

On Nov. 26, the World Health Organization declared Omicron the latest COVID-19 variant of concern, and vaccine makers jumped on the news. Moderna quickly announced that it was developing an Omicron-specific vaccine, while continuing to study both a higher dose of its currently authorized shot, and a combination vaccine that protects against one of the … Read more

There are still more questions about the Omicron variant than answers. While the mutations identified suggest it has the potential to be more resistant to vaccines, invade cells more efficiently and be more transmissible than other variants, it may also turn out to cause less severe disease or it could just simply fizzle out. However, … Read more